Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia

Ferran Nadeu, Julio Delgado, Cristina Royo, Tycho Baumann, Tatjana Stankovic, Magda Pinyol, Pedro Jares, Alba Navarro, David Martín-García, Sílvia Beà, Itziar Salaverria, Ceri Oldreive, Marta Aymerich, Helena Suárez-Cisneros, Maria Rozman, Neus Villamor, Dolors Colomer, Armando López-Guillermo, Marcos González, Miguel AlcocebaMaria José Terol, Enrique Colado, Xose S Puente, Carlos López-Otín, Anna Enjuanes, Elías Campo

Research output: Contribution to journalArticlepeer-review

165 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry